
AnnMarie Hipsley, DPT, PhD, met with Ophthalmology Times Europe to discuss Ace Vision Group's microporation therapeutic technology, used to treat presbyopia.

AnnMarie Hipsley, DPT, PhD, met with Ophthalmology Times Europe to discuss Ace Vision Group's microporation therapeutic technology, used to treat presbyopia.

Hundreds of previously-unknown genes could be vital for early detection and treatment.

Preliminary results indicate significant improvement for patients and ‘very good safety profile’